Market Research Report

A quick peek into the report

1.1 Definition of Image Guided Interventional systems (by Segment)
1.2 Advantages of Image Guided Interventional Systems
1.3 Global Image Guided Interventional Systems Market Scenario

2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Shifting Focus Toward Value Oriented Healthcare Model
2.2.2 Immense Growth in Emerging Markets
2.2.3 Strong Increase in Demand for Enhanced Imaging Technology
2.2.4 Rising Adoption Rate of Minimally Invasive Surgeries
2.2.5 Frequent Launch of New Technology
2.2.6 Innovation of Multimodality Systems
2.2.7 Pricing Pressure on the Manufacturers Owing to Government Reforms
2.3 Market Challenges
2.3.1 Real Time Imaging Challenges
2.3.2 Cost Limitation Challenging Service Affordability
2.3.3 Significant Product Recalls
2.4 Market Opportunities
2.4.1 Rising Adoption of Hybrid Imaging among End Users
2.4.2 Installation of Hybrid Operating Room
2.5 Market Trends
2.5.1 High-end Innovative Product Launches
2.5.2 Enhanced Product Innovations to Propel Market Growth
2.5.3 Companies Opting Unique Strategies to Remain Competent
2.5.4 Upsurge in Utilization of Intraoperative Imaging for Treatment
2.5.5 Growing Acceptance of Intraoperative Imaging Devices over Other Imaging Devices for Diagnosis/Preventive Therapies

3.1 Key Development and Strategies
3.1.1 Product Launches
3.1.2 Mergers and Acquisitions
3.1.3 Partnerships, Agreements, and Expansion
3.1.4 Others (Awards, Milestones, and Achievements)
3.2 Market Share Analysis

4.1 Image Guided Interventional Systems Market Supply Chain
4.2 Image Guided Interventional Systems Regulatory Pathway
4.2.1 North America (The U.S. and Canada) Medical Device Regulations
4.2.2 Europe Medical Device Regulations
4.2.3 Asia-Pacific Medical Device Regulations
4.2.4 Latin America Medical Device Regulations
4.2.5 Middle East and Africa Medical Device Regulations
4.3 Regulatory Bodies

5.1 Overview
5.2 Single Plane Systems
5.3 Bi-plane Systems

6.1 Overview
6.2 Intraoperative MRI Scanner
6.3 Intraoperative CT Scanner
6.4 Vascular Interventional Systems
6.5 Intravascular Ultrasound (IVUS), Fractional Flow Reserves, and Instantaneous Wave Free Ratio
6.6 Intraoperative Ultrasound
6.7 Endoscopes System
6.8 Fluoroscopy
6.9 Others (Digital and Hybrid System)

7.1 Overview
7.2 Cardiology
7.3 Neurology
7.4 Oncology
7.5 Gastroenterology
7.6 Orthopedics
7.7 ENT Surgery
7.8 Other Applications (Urology, Cranial, and Pain Management and Oral Interventions)

8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers
8.4 Specialty Clinics

9.1 Overview
9.2 North America
9.2.1 North America Market Dynamics
9.2.2 The U.S.
9.2.3 Canada
9.3 Europe
9.3.1 Europe Market Dynamics
9.3.2 Germany
9.3.3 The U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Rest-of-Europe
9.4 APAC
9.4.1 APAC Market Dynamics
9.4.2 China
9.4.3 India
9.4.4 Japan
9.4.5 Australia
9.4.6 Singapore
9.4.7 Thailand
9.4.8 Malaysia
9.4.9 Rest-of-APAC
9.5 Latin America
9.5.1 Latin America Market Dynamics
9.5.2 Brazil
9.5.3 Mexico
9.5.4 Argentina
9.5.5 Rest-of-Latin America
9.6 Middle East and Africa
9.6.1 Middle East and Africa Market Dynamics
9.6.2 South Africa
9.6.3 North Africa
9.6.4 Saudi Arabia
9.6.5 United Arab Emirates (UAE)
9.6.6 Rest-of-MEA

10.1 Arthrex, Inc.
10.1.1 Company Overview
10.1.2 Overall Product Portfolio
10.1.3 Product Offerings for Image guided interventional systems
10.1.4 Corporate Summary
10.1.5 Recent Developments
10.1.6 SWOT Analysis
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Overall Product Portfolio
10.2.3 Corporate Summary
10.2.4 Product Offerings for Image guided interventional systems
10.2.5 Financials
10.2.5.1 Financial Summary
10.2.6 Recent Developments
10.2.7 SWOT Analysis
10.3 Boston Scientific Corporation
10.3.1 Company Overview
10.3.2 Overall Product Portfolio
10.3.3 Corporate Summary
10.3.4 Boston Scientific Corporation Product Offerings
10.3.5 Boston Scientific Corporation Target Product
10.3.6 Financials
10.3.6.1 Financial Summary
10.3.7 Recent Developments
10.3.8 SWOT Analysis
10.4 Canon Inc.
10.4.1 Company Overview
10.4.2 Overall Product Portfolio
10.4.3 Corporate Summary
10.4.4 Financials
10.4.4.1 Financial Summary
10.4.5 SWOT Analysis
10.5 C. R. Bard, Inc.
10.5.1 Company Overview
10.5.2 Becton, Dickinson and Company: Company Overview
10.5.3 Overall Product Portfolio
10.5.4 Corporate Summary
10.5.5 Product Offerings for Image guided interventional systems
10.5.6 Financials
10.5.6.1 Financial Summary
10.5.7 Recent Developments
10.5.8 SWOT Analysis
10.6 DENTSPLY SIRONA Inc.
10.6.1 Company Overview
10.6.2 Overall Product Portfolio
10.6.3 Corporate Summary
10.6.4 Product Offerings for Image guided interventional systems
10.6.5 Financials
10.6.5.1 Financial Summary
10.6.6 Recent Developments
10.6.7 SWOT Analysis
10.7 Elekta AB
10.7.1 Company Overview
10.7.2 Overall Product Portfolio
10.7.3 Corporate Summary
10.7.4 Product Offerings for Image guided interventional systems
10.7.5 Financials
10.7.5.1 Financial Summary
10.7.6 Recent Developments
10.7.7 SWOT Analysis
10.8 Fujifilm Holdings Corporation
10.8.1 Company Overview
10.8.2 Overall Product Portfolio
10.8.3 Corporate Summary
10.8.4 Product Offerings for Image guided interventional systems
10.8.5 Financials
10.8.5.1 Financial Summary
10.8.6 SWOT Analysis
10.9 GE Healthcare
10.9.1 Company Overview
10.9.2 GE Healthcare Product Portfolio
10.9.3 Corporate Summary
10.9.4 Product Offerings for Image guided interventional systems
10.9.5 Financials
10.9.5.1 Financial Summary
10.9.6 Recent Developments
10.9.7 SWOT Analysis
10.10 Hitachi Ltd.
10.10.1 Company Overview
10.10.2 Overall Product Portfolio
10.10.3 Product Offerings for Image guided interventional systems
10.10.4 Corporate Summary
10.10.5 Financials
10.10.5.1 Financial Summary
10.10.6 Recent Developments
10.10.7 SWOT Analysis
10.11 Hologic, Inc.
10.11.1 Company Overview
10.11.2 Hologic, Inc. Overall Product Portfolio
10.11.3 Corporate Summary
10.11.4 Product Offerings for Image guided interventional systems
10.11.5 Financials
10.11.5.1 Financial Summary
10.11.6 Recent Developments
10.11.7 SWOT Analysis
10.12 IMRIS Inc.
10.12.1 Company Overview
10.12.2 Overall Product Portfolio
10.12.3 Corporate Summary
10.12.4 SWOT Analysis
10.13 KARL STORZ SE & Co. KG
10.13.1 Company Overview
10.13.2 Overall Product Portfolio
10.13.3 Corporate Summary
10.13.4 Product Offerings for Image guided interventional systems
10.13.5 Recent Developments
10.13.6 SWOT Analysis
10.14 Koninklijke Philips N.V.
10.14.1 Company Overview
10.14.2 Overall Product Portfolio
10.14.3 Corporate Summary
10.14.4 Product Offerings for Image guided interventional systems
10.14.5 Financials
10.14.5.1 Financial Summary
10.14.6 Recent Developments
10.14.7 SWOT Analysis
10.15 Medtronic Plc
10.15.1 Company Overview
10.15.2 Overall Product Portfolio
10.15.3 Corporate Summary
10.15.4 Financials
10.15.4.1 Financial Summary
10.15.5 Recent Developments
10.15.6 SWOT Analysis
10.16 Olympus Corporation
10.16.1 Company Overview
10.16.2 Overall Product Portfolio
10.16.3 Product Offerings for Image guided interventional systems
10.16.4 Corporate Summary
10.16.5 Financials
10.16.5.1 Financial Summary
10.16.6 Recent Developments
10.16.7 SWOT Analysis
10.17 Shimadzu Corporation
10.17.1 Company Overview
10.17.2 Overall Product Portfolio
10.17.3 Product Offerings for Image guided interventional systems
10.17.4 Corporate Summary
10.17.5 Financials
10.17.5.1 Financial Summary
10.17.6 Recent Developments
10.17.7 SWOT Analysis
10.18 Siemens AG
10.18.1 Company Overview
10.18.2 Overall Product Portfolio
10.18.3 Corporate Summary
10.18.4 Financials
10.18.4.1 Financial Summary
10.18.5 Recent Developments
10.18.6 SWOT Analysis
10.19 Stryker Corporation
10.19.1 Company Overview
10.19.2 Overall Product Portfolio
10.19.3 Product Offerings for Image guided interventional systems
10.19.4 Financials
10.19.4.1 Financial Summary
10.19.5 Recent Developments
10.19.6 SWOT Analysis
10.20 Terumo Corporation
10.20.1 Company Overview
10.20.2 Overall Product Portfolio
10.20.3 Corporate Summary
10.20.4 Product Offerings for Image guided interventional systems
10.20.5 Financials
10.20.5.1 Financial Summary
10.20.6 SWOT Analysis

11.1 Scope of the Report
11.2 Image Guided Interventional Systems Market Research Methodology
11.2.1 Primary Data Sources
11.2.2 Secondary Data Sources
11.2.3 Assumptions and Limitations

Table 1 Global Image Guided Interventional Systems Market, 2017 and 2028
Table 2 Impact of Market Drivers
Table 3 Impact of Market Restraints
Table 2.1 Impact Analysis
Table 3.1 Description of Products Launched by Some of the Leading Companies
Table 3.2 Key Mergers and Acquisitions, 2016-2018
Table 3.3 Key Partnerships, Agreements, and Expansions, 2016-2017
Table 3.4 Key Awards and Achievements Events, 2016-2018
Table 4.1 List of Regulatory Bodies across the World
Table 9.1 Global Image Guided Interventional Systems Market (by Region), 2018-2028
Table 9.2 North America Image Guided Interventional Systems Market (by Country)
Table 9.3 Europe Image Guided Interventional Systems Market (by Country)
Table 9.4 APAC Image Guided Interventional Systems Market (by Country), $Billion, 2018-2028
Table 9.5 Latin America: Image Guided Interventional Systems Market (by Country), $Billion, 2018-2028
Table 9.6 Middle East and Africa: Image Guided Interventional Systems Market (by Country), $Million, 2018-2028
Table 10.1 Arthrex Inc.: Recent Developments
Table 10.2 B. Braun Melsungen AG: Recent Developments
Table 10.3 Boston Scientific Corporation: Recent Developments
Table 10.4 Becton, Dickinson and Company: Recent Developments
Table 10.5 DENTSPLY SIRONA Inc.: Recent Developments
Table 10.6 Elekta AB: Recent Developments
Table 10.7 GE Healthcare: Recent Developments
Table 10.8 Hitachi Ltd.: Recent Developments
Table 10.9 Hologic, Inc.: Recent Developments
Table 10.10 KARL STORZ SE & Co. KG: Recent Developments
Table 10.11 Koninklijke Philips N.V.: Recent Developments
Table 10.12 Medtronic Plc: Recent Developments
Table 10.13 Olympus Corporation: Recent Developments
Table 10.14 Shimadzu Corporation: Recent Developments
Table 10.15 Siemens AG: Recent Developments
Table 10.16 Stryker Corporation: Recent Developments

Figure 1 Global Image Guided Interventional Systems Market Snapshot
Figure 2 Key Market Trend and Opportunities
Figure 3 Market Statistics and Growth Parameters
Figure 4 Global Image Guided Interventional Systems Market (by Product Type), $Billion, 2017 and 2028
Figure 5 Global Image Guided Interventional Systems Market (by Modality), 2017 and 2028
Figure 6 Global Image Guided Interventional Systems Market (by Application), 2017 and 2028
Figure 7 Global Image Guided Interventional Systems Market (by End User), 2017 and 2028
Figure 8 Global Image Guided Interventional Systems Market Scenario (by Region), 2017 and 2028
Figure 9 Global Image Guided Interventional Systems Market Share Analysis (by Region), 2017 and 2028
Figure 1.1 Advantages of Image Guided Interventional Systems Market
Figure 1.2 Global Image Guided Interventional Systems Market, 2017-2028
Figure 2.1 Market Dynamics of Global Image Guided Interventional Systems Market
Figure 3.1 Share of the Key Developments and Strategies, 2016-2018
Figure 3.2 Product Launch/Up-gradation Share (by Companies)
Figure 3.3 Key Merger and Acquisitions Share (by Company), 2016-2018
Figure 3.4 Key Partnerships, Agreements, and Expansion Share (by Company), 2016-2018
Figure 3.5 Key Awards, Milestones, and Achievements Share (by Company), 2016-2018
Figure 3.6 Market Share Analysis: Global Image Guided Interventional Systems Market, 2016
Figure 3.7 Market Share Analysis: Global Image Guided Interventional Systems Market, 2017
Figure 4.1 Global Image Guided Interventional Systems Supply Chain
Figure 4.2 U.S. Medical Device Regulations
Figure 4.3 Europe Medical Device Regulations
Figure 4.4 Japan Medical Device Regulations
Figure 5.1 Global Image Guided Interventional Systems (by Product Type)
Figure 5.2 Single Plane systems – Advantages and Disadvantages
Figure 5.3 Single Plane Image Guided Interventional Systems Market, 2017-2028
Figure 5.4 Bi-plane System: Advantages and Disadvantages
Figure 5.5 Bi-Plane Systems Image Guided Interventional Systems Market Size, 2017-2028
Figure 6.1 Global Image Guided Interventional Systems Market (by Modality)
Figure 6.2 Global Image Guided Interventional Systems Market Size (by Modality), 2017-2028
Figure 6.3 Intraoperative MRI Image Guided Interventional Systems Market Size, 2017-2028
Figure 6.4 Intraoperative CT Scanner Image Guided Interventional Systems Market Size, 2017-2028
Figure 6.5 Vascular Intervention Systems Image Guided Interventional Systems Market Size, 2017-2028
Figure 6.6 Intravascular Ultrasound, Fractional Flow Reserves, and Instantaneous Wave Free Ratio Image Guided Interventional Systems Market Size, 2017-2028
Figure 6.7 Intraoperative Ultrasound Guided Interventional Systems Market Size, 2017-2028
Figure 6.8 Endoscopes System Guided Interventional Systems Market Size, 2017-2028
Figure 6.9 Fluoroscopy Guided Interventional Systems Market Size, 2017-2028
Figure 6.10 Others (Digital and Hybrid System) Guided Interventional Systems Market Size, 2017-2028
Figure 7.1 Global Image Guided Interventional Systems Market (by Application)
Figure 7.2 Global Image Guided Interventional Systems Market Size, (by Application), 2017-2028
Figure 7.3 Cardiology Image Guided Interventional Systems Market Size, 2017-2028
Figure 7.4 Neurology Image Guided Interventional Systems Market Size, 2017-2028
Figure 7.5 Oncology Image Guided Interventional Systems Market Size, 2017-2028
Figure 7.6 Size, Gastroenterological Image Guided Interventional Systems Market, 2017-2028
Figure 7.7 Orthopaedics Image Guided Interventional Systems Market Size, 2017-2028
Figure 7.8 ENT Surgery Image Guided Interventional Systems Market Size, 2017-2028
Figure 7.9 Other Applications (Urology, Cranial, and Pain Management and Oral Interventions) Image Guided Interventional Systems Market Size, 2017-2028
Figure 8.1 Global Image Guided Interventional Systems Market (by End User)
Figure 8.2 Global Image guided interventional systems market Size (by End User), 2017-2028
Figure 8.3 Hospital Image Guided Interventional Systems Market Size, 2017-2028
Figure 8.4 Ambulatory Surgical Centres Image Guided Interventional Systems Market Size, 2017-2028
Figure 8.5 Specialty Clinics Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.1 Global Image Guided Interventional Systems Market Scenario, 2017 and 2028
Figure 9.2 North America: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.3 North America: Image Guided Interventional Systems Market Dynamics
Figure 9.4 The U.S: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.5 Canada: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.6 Europe: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.7 Europe: Image Guided Interventional Systems Market Dynamics
Figure 9.8 Germany: Image Guided Interventional Systems Market, 2017-2028
Figure 9.9 The U.K: Image Guided Interventional Systems Market, 2017-2028
Figure 9.10 France: Image Guided Interventional Systems Market, 2017-2028
Figure 9.11 Spain: Image Guided Interventional Systems Market, 2017-2028
Figure 9.12 Italy: Image Guided Interventional Systems Market, 2017-2028
Figure 9.13 Rest-of-Europe: Image Guided Interventional Systems Market, 2017-2028
Figure 9.14 APAC: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.15 APAC: Image Guided Interventional Systems Market Dynamics
Figure 9.16 China: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.17 India: Image Guided Interventional Systems Market, 2017-2028
Figure 9.18 Japan: image Guided Interventional Systems Market, (2018-2028)
Figure 9.19 Australia: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.20 Singapore: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.21 Thailand: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.22 Malaysia: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.23 Rest-of-APAC: Image Guided Interventional Systems Market, 2017-2028
Figure 9.24 Latin America: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.25 Latin America: Image Guided Interventional Systems Market Dynamics
Figure 9.26 Brazil: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.27 Mexico: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.28 Argentina: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.29 Rest-of-Latin America: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.30 Middle East and Africa: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.31 Middle East and Africa: Image Guided Interventional Systems Market Dynamics
Figure 9.32 South Africa: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.33 North Africa: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.34 Saudi Arabia: Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.35 United Arab Emirates (UAE): Image Guided Interventional Systems Market Size, 2017-2028
Figure 9.36 Rest-of-MEA: Image Guided Interventional Systems Market Size, 2017-2028
Figure 10.1 Share of Companies (by Ownership and Region)
Figure 10.2 Arthrex Inc.: Product/Service Offerings
Figure 10.3 Arthrex Inc.: Image guided interventional systems Product Portfolio
Figure 10.4 Arthrex Inc.: SWOT Analysis
Figure 10.5 B. Braun Melsungen AG: Product/Service Offerings
Figure 10.6 B. Braun Melsungen AG: Overall Product Portfolio
Figure 10.7 B. Braun Melsungen AG: Image guided interventional systems Product Portfolio
Figure 10.8 B. Braun Melsungen AG: Overall Financials (2015-2017)
Figure 10.9 B. Braun Melsungen AG: Revenue by Division (2015-2017)
Figure 10.10 B. Braun Melsungen AG: Revenue (by Region), 2015-2017
Figure 10.11 B. Braun Melsungen AG: SWOT Analysis
Figure 10.12 Boston Scientific Corporation: Product/Service Offerings
Figure 10.13 Boston Scientific Corporation: Product Offerings
Figure 10.14 Boston Scientific Corporation: Target Product
Figure 10.15 Boston Scientific Corporation: Overall Revenue (2015 – 2017)
Figure 10.16 Boston Scientific Corporation: Revenue by Business Segments (2015 – 2017)
Figure 10.17 Boston Scientific Corporation: Revenue from Target Segment (Urology and Pelvic Health), (2015 – 2017)
Figure 10.18 Boston Scientific Corporation: Revenue (by Region), 2015 – 2017
Figure 10.19 Boston Scientific Corporation: SWOT Analysis
Figure 10.20 Canon Inc.: Product/Service Offerings
Figure 10.21 Canon Inc.: Overall Product Portfolio
Figure 10.22 Canon Inc.: Overall Revenue (2015 – 2017)
Figure 10.23 Canon Inc.: Revenue by Business Segment (2015 – 2017)
Figure 10.24 Canon Inc.: Revenue (by Region), 2015 – 2017
Figure 10.25 Canon Inc.: SWOT Analysis
Figure 10.26 Becton, Dickinson and Company: Product/Service Offerings
Figure 10.27 Becton, Dickinson and Company: Image guided interventional systems
Figure 10.28 Becton, Dickinson and Company: Overall Revenue (2015 – 2017)
Figure 10.29 Becton, Dickinson and Company: Revenue by Business Segments (2015 – 2017)
Figure 10.30 Becton, Dickinson and Company: Revenue (by Region), 2015 – 2017
Figure 10.31 Becton, Dickinson and Company: SWOT Analysis
Figure 10.32 DENTSPLY SIRONA Inc.: Product/Service Offerings
Figure 10.33 DENTSPLY SIRONA Inc.: Image guided interventional systems Product Portfolio
Figure 10.34 DENTSPLY SIRONA Inc.: Overall Revenue (2015 -2017)
Figure 10.35 DENTSPLY SIRONA Inc.: Revenue by Business Segment (2015 – 2017)
Figure 10.36 DENTSPLY SIRONA Inc.: Revenue (by Region), 2015 – 2017
Figure 10.37 DENTSPLY SIRONA Inc.: SWOT Analysis
Figure 10.38 Elekta AB: Product/Service Offerings
Figure 10.39 Elekta AB: Image guided interventional systems Product Portfolio
Figure 10.40 Elekta AB: Overall Revenue (2015 – 2017)
Figure 10.41 Elekta AB: Revenue by Segments (2015 – 2017)
Figure 10.42 Elekta AB: Revenue (by Region), 2015 – 2017
Figure 10.43 Elekta AB: SWOT Analysis
Figure 10.44 Fujifilm Holdings Corporation: Product/Service Offerings
Figure 10.45 Fujifilm Holdings Corporation: Image guided interventional systems Product Portfolio
Figure 10.46 Fujifilm Holdings Corporation: Overall Revenue (2015 – 2017)
Figure 10.47 Fujifilm Holdings Corporation: Revenue by Segment (2015 – 2017)
Figure 10.48 Fujifilm Holdings Corporation: Revenue (by Region), 2015 – 2017
Figure 10.49 Fujifilm Holdings Corporation: SWOT Analysis
Figure 10.50 GE Healthcare: Product/Service Offerings
Figure 10.51 GE Healthcare: Image guided interventional systems Product Portfolio
Figure 10.52 GE Healthcare: Image guided interventional systems Product Portfolio
Figure 10.53 GE Healthcare: Overall Revenue (2015 – 2017)
Figure 10.54 GE Healthcare: Revenue by Business Segments
Figure 10.55 GE Healthcare: Revenue (by Region), 2015-2017
Figure 10.56 GE Healthcare: SWOT Analysis
Figure 10.57 Hitachi Ltd.: Product/Service Offerings
Figure 10.58 Hitachi Ltd.: Image guided interventional systems Product Portfolio
Figure 10.59 Hitachi Ltd.: Overall Revenue (2015 -2017)
Figure 10.60 Hitachi Ltd.: Revenue by Business Segment (2015 – 2017)
Figure 10.61 Hitachi Ltd.: Revenue (by Region), 2015–2017
Figure 10.62 Hitachi Ltd.: SWOT Analysis
Figure 10.63 Hologic, Inc.: Product/Service Offerings
Figure 10.64 Hologic, Inc.: Image guided interventional systems Product Portfolio
Figure 10.65 Hologic, Inc.: Overall Revenue (2015 - 2017)
Figure 10.66 Hologic, Inc.: Revenue by Business Segments (2015 – 2017)
Figure 10.67 Hologic, Inc.: Revenue (by Region), 2015 – 2017
Figure 10.68 Hologic, Inc.: SWOT Analysis
Figure 10.69 IMRIS INC.: Product/Service Offerings
Figure 10.70 IMRIS INC.: SWOT Analysis
Figure 10.71 KARL STORZ SE & Co. KG: Product/Service Offerings
Figure 10.72 KARL STORZ SE & Co. KG: Image guided interventional systems Product Portfolio
Figure 10.73 KARL STORZ SE & Co. KG: SWOT Analysis
Figure 10.74 Koninklijke Philips N.V.: Product/Service Offerings
Figure 10.75 Koninklijke Philips N.V.: Image guided interventional systems Product Portfolio
Figure 10.76 Koninklijke Philips N.V.: Overall Revenue (2015 – 2017)
Figure 10.77 Koninklijke Philips N.V.: Revenue by Business Segment (2015 – 2017)
Figure 10.78 Koninklijke Philips N.V.: Revenue (by Region), 2015 – 2017
Figure 10.79 Koninklijke Philips N.V.: SWOT Analysis
Figure 10.80 Medtronic Plc: Product/Service Offerings
Figure 10.81 Medtronic Plc: Image guided interventional systems Product Portfolio
Figure 10.82 Medtronic Plc: Overall Revenue (2015 -2017)
Figure 10.83 Medtronic Plc: Revenue by Business Segment (2015 -2017)
Figure 10.84 Medtronic Plc: Revenue (by Region), 2015 – 2017
Figure 10.85 Medtronic Plc: SWOT Analysis
Figure 10.86 Olympus Corporation: Product/Service Offerings
Figure 10.87 Olympus Corporation: Image guided interventional systems Product Portfolio
Figure 10.88 Olympus Corporation: Overall Revenue (2015 – 2017)
Figure 10.89 Olympus Corporation: Revenue by Business Segment (2015 – 2017)
Figure 10.90 Olympus Corporation: Revenue (by Region), 2015 – 2017
Figure 10.91 Olympus Corporation: SWOT Analysis
Figure 10.92 Shimadzu Corporation: Product/Service Offerings
Figure 10.93 Shimadzu Corporation: Image guided interventional systems Product Portfolio
Figure 10.94 Shimadzu Corporation: Image guided interventional systems Product Portfolio
Figure 10.95 Shimadzu Corporation: Overall Revenue (2015 – 2017)
Figure 10.96 Shimadzu Corporation: Revenue by Business Segments (2015 – 2017)
Figure 10.97 Shimadzu Corporation: Revenue (by Region), 2015 -2017
Figure 10.98 Shimadzu Corporation: SWOT Analysis
Figure 10.99 Siemens AG: Product/Service Offerings
Figure 10.100 Siemens Healthineers: Overall Product Portfolio
Figure 10.101 Siemens AG: Overall Revenue (2015 – 2017)
Figure 10.102 Siemens Healthineers: Revenue by Business Segment (2015 – 2017)
Figure 10.103 Siemens Healthineers: Revenue (by Region), 2015 – 2017
Figure 10.104 Siemens AG: SWOT Analysis
Figure 10.105 Stryker Corporation: Product/Service Offerings
Figure 10.106 Stryker Corporation: Image guided interventional systems Product Portfolio
Figure 10.107 Stryker Corporation: Overall Revenue (2015 – 2017)
Figure 10.108 Stryker Corporation: Revenue by Business Segment (2015 – 2017)
Figure 10.109 Stryker Corporation: Revenue (by Region), 2015 – 2017
Figure 10.110 Stryker Corporation: SWOT Analysis
Figure 10.111 Terumo Corporation: Product/Service Offerings
Figure 10.112 Terumo Corporation: Image guided interventional systems Product Portfolio
Figure 10.113 Terumo Corporation: Overall Revenue (2015 – 2017)
Figure 10.114 Terumo Corporation: Revenue by Business Segment (2015 – 2017)
Figure 10.115 Terumo Corporation: Revenue (by Region), 2015 -2017
Figure 10.116 Terumo Corporation: SWOT Analysis
Figure 11.1 Global image Guided Interventional Systems Market Segmentation
Figure 11.2 Image Guided Interventional Systems Market Research Methodology
Figure 11.3 Secondary Data Sources
Figure 11.4 Top-down and Bottom-up Approach
Figure 11.5 Image Guided Interventional Systems Market: Influencing Factors

Market Overview

Image guided interventions consist of devices designed specifically to be utilized for performing precision based surgical interventions. The rising advent of the image guided intervention systems such as intraoperative MRI scanners, intraoperative CT scanners, intravascular intervention systems, intravascular ultrasound, fractional flow reserves, instantaneous wave-free ratio (iFR), endoscopes, fluoroscopy systems and other hybrid and digital devices has helped in the overall growth of the image guided interventions market. The high frequency in the product launches is the prime driving force that is expected to bolster the rapid market growth over the forecast period 2018-2028. Additionally, the strategies such as merger & acquisition, partnership, collaboration and expansion, along with recognitions such as awards and milestone achievement are likely to aid the deep penetration of such devices in emerging economies over the forecast period 2018-2028.

The product type such as single and bi-plane system provide high resolution, 2D/3D real time data at high definition to ultra-high definition (4K) to provide accurate and precise information about the particular area to operate on. Such systems have helped in achieving high precision, efficiency and success rate in various interventional procedures. Image guided interventions are used for applications such as cardiology, neurology, oncology, gastroenterology, orthopedics, ENT surgery and various other applications (Urology, Cranial, Pain Management, Oral, Maxillofacial Surgery etc.) interventions. Cardiology has acquired the largest share in this market and oncology-based applications are likely to grow at high CAGR over the forecast period 2018-2028 owing to factors such as rising incidence of oncology cases and high rate of minimally invasive surgeries.

The purpose of conducting this study is to gain a holistic view about the image guided interventions market in terms of factors such as recent trends and technological advancements occurring in this market. The scope of this study is based upon conducting a detailed analysis of the products associated with the global image guided interventions market, across the different regions. The global image guided interventions market is segment into five different parts such as by product type, by modality, by application, by end user, and by region. The global image guided interventions market is expected to reach $6,509.3 million by 2028.

The demand for technologically advanced, high resolution, and affordable image guided interventional products owing to such factors the image guided interventions market is expected to witness the robustly paced growth over the forecast period 2018-2028. Moreover, the rapid growth of the market in the emerging economies such as India, Thailand, Malaysia, Sudan, Nigeria, Saudi Arabia, UAE, and Argentina among others, is expected to bolster the market growth over the forecast period (2018-2028). The single plane systems sub segment is expected to dominate the market and is attributed to grow at high pace in comparison to bi-plane systems. Further, the Intravascular Ultrasound, Fractional Flow Rate and instantaneous wave-free ratio (iFR) is the fastest growing sub-segment among the modality segment over the forecast period 2018-2028.

Based on the region the global image guided interventions market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading contributor to the global image guided interventions market and is estimated to have captured 33.4% of the global market in 2017. However, the Asia Pacific is expected to grow at a CAGR of 7.3% over the forecast period followed by North America.

The key players who have been contributing significantly to the ambulatory devices market include GE Healthcare, Hitachi Ltd., Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Olympus Corporation, Siemens AG, KARL STORZ GmbH & Co. KG, Stryker Corporation, Medtronic Plc, Shimadzu Corporation, Arthrex Inc., Koninklijke Philips N.V., B. Braun Melsungen AG, Hologic Inc., Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Elekta AB, Sirona Dentsply Inc. and Terumo Corporation among others.

Key Questions Answered in this Report

• How did the image guided interventions market evolve and what is its scope in the future?
• What are the major market drivers, challenges and opportunities in the global image guided interventions devices market?
• What are the key strategies that are being adopted by the key players to sustain in this market?
• What key factors are influencing the end users in the industry?
• How the image guided interventions systems are being regulated and enter the market?
• How the supply chain works, and the product approval provided by various government organizations will affect the global image guided interventions market?
• What was the market size of the leading segments and sub-segments of the global image guided interventions market in 2017?
• How will the industry evolve during the forecast period 2018- 2028?
• What are the major benefits of the implementation of image guided interventions in different field of applications including cardiology, neurology, oncology, gastroenterology, orthopedics, ENT surgery and other applications?
• Who are the key players in the global image guided interventions market and what are their contributions?

Report Description

Global medical device industry is driven by the innovative product launches, advancement in the devices and solution-oriented approach of the manufacturers towards product development. The medical device industry is growing at roust pace owing to the high demand for diagnostic and therapeutic devices treat acute and chronic diseases. There is constant increase in the number of cardiac, neurological, gastroenterological, and orthopaedic diseases among other diseases. Therefore, the image guided interventions market is growing at decent pace as such diseases requires interventional approach for effective treatment. Further, the demand is fuelled by significant improvement in the overall medical devices regulatory and formation of dedicated government bodies for medical device approval. Furthermore, substantial increase in the healthcare expenditure, has attracted more attention of investors for the image guided interventions market. Therefore, to sustain in the highly competitive market, the image guided interventions are gradually evolving as an advanced therapeutic tool in medical device industry with additional benefits, including high precision, live imaging, easy to handle and cost-effectiveness. Additional, the manufacturers in the image guided interventions market seeking relaxation in the legal requirements and regulations to abridge the R&D as well as the approval process for their products. Thus, providing companies to devote more time to solve complex challenges by innovating new components or technologies to attain better product efficiency.

The purpose of this study is to gain a holistic view of the image guided interventions market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global image guided interventions market, across different regions. The market has been segmented into ‘product type’, ‘modality’, ‘application’, ‘end-user’ and ‘regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global image guided interventions market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study highlights the factors governing the regulatory scenario and framework for a comprehensive understanding of the global image guided interventions market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.

The key players who have been contributing significantly to the image guided interventions market include Arthrex Inc., B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Canon Inc, Dentsply Sirona Inc., Elekta AB, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd., Hologic Inc., IMRIS Inc., Koninklijke Philips N.V., KARL STORZ SE & Co. KG, Medtronic Plc, Olympus Corporation, Stryker Corporation, Siemens AG, Shimadzu Corporation, Terumo Corporation.